CTRI/2022/03/040921
Active, not recruiting
未知
A ProSpective, multicentre, registry to evalUate the Clinical outCome of Encruso RAL-EverolimusEluting Coronary Stent System in real world percutaneOus coronary revasculaRization in Indian population- SUCCESSOR - SUCCESSOR
ano Therapeutics Private Limited0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ano Therapeutics Private Limited
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Male or female patient who is 18 years and above
- •2\.Patients undergoing percutaneous coronary intervention with Encruso RAL\-Everolimus Eluting Coronary Stent System
- •3\.Patient or legal guardian understands the study requirements and provides written informed consent
- •4\.Patient who is on dual antiplatelet therapy for at least 6 months post procedure
Exclusion Criteria
- •1\.Patient has known hypersensitivity or allergies to Aspirin, Heparin,Clopidogrel, Ticlopidine, Everolimus or similar drugs, or any other
- •analogue or derivative, cobalt, chromium, or contrast media
- •2\.Patient with life expectancy less than 2 years
- •3\.Pregnant and lactating females or planning to become pregnant while in the study
- •4\.Patient currently participating in another investigational drug or device clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A follow up study to evaluate the safety and effectiveness of tissue valve (aortic) among Indian patientsHealth Condition 1: I358- Other nonrheumatic aortic valve disordersCTRI/2022/08/044557SRM Institutes for Medical Science SIMS
Recruiting
Not Applicable
Evaluation of the Impact of Fractional flow reserve and Optical Coherence Tomography on the Outcomes of Percutaneous coronary intervention in Diabetic PatientsCTRI/2021/09/036375Ananthapuri Hospitals and Research Institute
Recruiting
Not Applicable
Metastatic ColoRectal cancer India RegistryHealth Condition 1: C189- Malignant neoplasm of colon, unspecifiedCTRI/2022/07/043968Dr Reddys Laboratories
Withdrawn
Not Applicable
A Multi-Center InternatiONal Registry to Evaluate the Efficacy oF Imaging with Opto-acoustics to Diagnose BrEast CaNCErNL-OMON46537Seno Medical Instruments, Inc.150
Active, not recruiting
Not Applicable
A Multicenter, Prospective, Long-term Registry of children with Crohn's Disease or Ulcerative ColitisEUCTR2008-005237-30-NLJanssen Biologics B.V.6,000